Before You Choose a Hub Model, Pressure-Test Your Patient Services Infrastructure

For many pharmaceutical and biotech teams, the patient services model decision used to feel relatively straightforward.

Outsource the hub.

Build internally.

Or find a partner to manage the work.

Today, that decision is more complicated.

For pharma and biotech teams, patient services infrastructure is what determines whether a hub model can support access, affordability, reporting, and long-term scalability.

Manufacturers are launching into an access environment shaped by medical and pharmacy benefit complexity, rising affordability pressure, provider burden, tighter compliance expectations, and greater demand for real-time visibility. At the same time, many teams want more control over the patient experience without overbuilding internal infrastructure before they are ready.

That is why the question is no longer simply:

Should we outsource or insource patient services?

The better question is:

What infrastructure does our program need to support the model we choose?

The model only works if the infrastructure works

A patient services model can look right on paper and still struggle in execution.

A fully outsourced model may offer speed and experienced support, but if workflows are disconnected, manufacturers may lack the visibility they need to understand where patients, providers, or field teams are getting stuck.

An insourced model may offer more control, but it also requires staffing, technology, reporting, compliance oversight, training, escalation pathways, and operational readiness.

A hybrid model can offer the best of both worlds, but only when roles, workflows, systems, and responsibilities are clearly defined.

The structure matters. But the infrastructure underneath it matters just as much.

What Patient Services Infrastructure Needs to Support

Modern patient services programs need to do more than manage cases. They need to support the full access journey in a way that can adapt as brand needs evolve.

That means the infrastructure should be able to support:

• Connected intake and case management

• Benefit verification and prior authorization workflows

• Medical and pharmacy benefit coordination

• Provider office visibility into case status

• Field reimbursement team access to timely information

• PAP, bridge, copay, and affordability workflows

• Pharmacy coordination and prescription routing

• Reporting that shows more than activity

• Quality, compliance, and audit readiness

• The ability to scale or transition as the program matures

Without that foundation, teams often compensate with manual workarounds, duplicate reporting, status calls, spreadsheets, and disconnected vendor updates.

Those workarounds may keep a program moving in the short term, but they are not a sustainable access strategy.

The risk of choosing the model before evaluating the operating reality

A manufacturer may choose a fully outsourced model because launch timing is tight.

Another may choose a hybrid model because it wants more control without carrying a full internal team.

Another may want to insource because the brand requires close ownership of patient experience, data, and field coordination.

Any of those decisions may be appropriate.

The risk comes when the decision is made before the operating reality is fully understood.

Before choosing a model, manufacturers should be asking:

• Where do we need control, and where do we need support?

• What workflows are most likely to create friction for providers?

• How will field teams know where access barriers are emerging?

• How will reimbursement, affordability, pharmacy, and adherence workflows connect?

• What reporting do we need to make decisions, not just track activity?

• How will quality and compliance be built into day-to-day execution?

• Can the model evolve as patient volume, market access dynamics, or internal capabilities change?

These questions do not point every manufacturer to the same answer. They help clarify what the model needs to do.

Building for launch and what comes next

Specialty launches rarely stay static.

Volume changes. Payer requirements shift. Affordability needs evolve. Provider expectations increase. Internal teams mature. Commercial strategy changes. A model that works at launch may need to expand, transition, or adapt over time.

That is why flexible infrastructure matters.

The goal is not to pick the most complex model. It is to build a model that fits the therapy, the organization, the access environment, and the patient journey, while leaving room to grow.

At eMAX Health Patient Services, we help manufacturers design patient support models across fully outsourced, hybrid, and insourced structures, supported by experienced patient services teams and HealthPACER® technology.

Because the right model is not just about who does the work.

It is about whether the infrastructure can support the work, the stakeholders, and the patients who depend on it.

If your team is evaluating a patient services model for launch or rethinking an existing program, now is the time to pressure-test the infrastructure behind it.

Schedule a capabilities discussion with Mary Lynn Kelley, President of eMAX Health Patient Services, to explore which model may best support your brand’s access strategy.